CAR T Cells in Advanced R/R Lymphoma: Keeping Patients Alive – Medscape
News-Medical.net |
CAR T Cells in Advanced R/R Lymphoma: Keeping Patients Alive
Medscape ATLANTA — New longer-term clinical data with chimeric antigen receptor (CAR) T cells now reported for patients with refractory and relapsed non-Hodgkin's lymphoma show that the responses are durable in about half of those treated, with the suggestion … CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients CAR T-Cell Therapies Drive Outcomes in Lymphoma, Myeloma Autolus presents data for pan-checkpoint blocking tech to restore CAR T-cells' function |
